FDA Approves Johnson & Johnson's Prezista For HIV-Positive People Who Have Never Taken Antiretrovirals (Medical News Today)
FDA on Tuesday approved Johnson & Johnson's protease inhibitor Prezista for use by people who have never taken antiretroviral drugs in the past, the Wall Street Journal reports. FDA in 2006 approved Prezista for HIV-positive people who had developed resistance to other drugs.

The FDA Approves Production Process Strategy Of Aplidin(R), New Marine-Derived Anti-Tumor Agent, Proposed By PharmaMar (Medical News Today)
The Food and Drug Administration (FDA) has accepted the proposal made by PharmaMar, of the Zeltia Group for the production process of Aplidin , a new marine-derived anti-tumor agent, in clinical development for the treatment of hematological and solid tumors. The starting materials for the initiation of the production process have also been approved.